Legend Biotech (LEGN) Valuation Check After Strong Revenue Growth And Narrowing Quarterly Loss

Simply Wall St.05-13

AdvertisementLegend Biotech’s Earnings Spark Fresh Interest in the Stock Legend Biotech (LEGN) recently released first quarter 2026 results, reporting revenue of US$305.1 million and a net loss of US$...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2635273668?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","is_english":true,"pubTime":"2026-05-13 08:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2635273668","market":"sg","top_or_hot":-1,"title":"Legend Biotech (LEGN) Valuation Check After Strong Revenue Growth And Narrowing Quarterly Loss","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementLegend Biotech’s Earnings Spark Fresh Interest in the Stock Legend Biotech (LEGN) recently released first quarter 2026 results, reporting revenue of US$305.1 million and a net loss of US$...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/legend-biotech-legn-valuation-check-after-strong-revenue-gro\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Legend Biotech (LEGN) Valuation Check After Strong Revenue Growth And Narrowing Quarterly Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLegend Biotech (LEGN) Valuation Check After Strong Revenue Growth And Narrowing Quarterly Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-13 08:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/legend-biotech-legn-valuation-check-after-strong-revenue-gro><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementLegend Biotech’s Earnings Spark Fresh Interest in the Stock Legend Biotech (LEGN) recently released first quarter 2026 results, reporting revenue of US$305.1 million and a net loss of US$...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/legend-biotech-legn-valuation-check-after-strong-revenue-gro\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LEGN","symbol_name":"传奇生物","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/legend-biotech-legn-valuation-check-after-strong-revenue-gro","article_id":"2635273668","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/legend-biotech-legn-valuation-check-after-strong-revenue-gro","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2635273668","pubTimestamp":1778633953,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Legend Biotech’s Earnings Spark Fresh Interest in the Stock\nLegend Biotech (LEGN) recently released first quarter 2026 results, reporting revenue of US$305.1 million and a net loss of US$54.3 million. This compares with revenue of US$195 million and a net loss of US$101 million a year earlier.\nSee our latest analysis for Legend Biotech.\nLegend Biotech’s 1 day share price return of 10.48% came alongside the earnings release, while the 30 day share price return of 55.62% suggests momentum has...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"LEGN":"传奇生物","XBI":"SPDR S&P Biotech ETF"},"translate_title":"传奇生物（LEGN）在收入强劲增长和季度亏损收窄后进行估值检查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LEGN":1.5,"XBI":1.5},"content_text":"AdvertisementLegend Biotech’s Earnings Spark Fresh Interest in the Stock Legend Biotech (LEGN) recently released first quarter 2026 results, reporting revenue of US$305.1 million and a net loss of US$54.3 million. This compares with revenue of US$195 million and a net loss of US$101 million a year earlier. See our latest analysis for Legend Biotech. Legend Biotech’s 1 day share price return of 10.48% came alongside the earnings release, while the 30 day share price return of 55.62% suggests momentum has picked up recently, even though the 1 year total shareholder return declined 9.07%. If this kind of rebound in biotech catches your eye, it could be worth scanning other healthcare names using our screener of 33 healthcare AI stocks. With revenue at US$305.1 million, losses narrowing and the stock up more than 50% over 30 days, the key question now is whether Legend Biotech is still trading at a discount or if the market is already pricing in a higher valuation. Most Popular Narrative: 50.6% Undervalued The most followed narrative pegs Legend Biotech's fair value at $57.24, which is roughly double the last close of $28.26, and frames the upside around multiple myeloma execution.  Significant expansion potential in both earlier lines of therapy and frontline settings for multiple myeloma, driven by strong survival data, ongoing clinical trials (CARTITUDE-5 and -6), and label updates that increase patient access, setting up long-term revenue acceleration as the patient pool widens.  Read the complete narrative. Curious what kind of revenue path and margin shift sit behind that valuation gap? The narrative leans on rapid top line growth, a sharp swing to profitability, and a richer future earnings multiple than the broader biotech sector. Result: Fair Value of $57.24 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, you still need to keep in mind that Legend Biotech depends heavily on CARVYKTI and faces rising competition that could pressure future revenue and margins. Find out about the key risks to this Legend Biotech narrative. Next Steps Does this narrative feel optimistic or cautious to you? If you want to move quickly from headline takeaways to your own view, start by checking the 2 key rewards. Looking for more investment ideas? If Legend Biotech has sharpened your interest, do not stop here. Use the Simply Wall Street Screener to spot other opportunities before they move without you.  Target potential mispricings by searching for stocks that combine quality and value through the 45 high quality undervalued stocks. Prioritize resilience by focusing on companies screened for strong finances using the solid balance sheet and fundamentals stocks screener (46 results). Get ahead of the crowd by reviewing the screener containing 22 high quality undiscovered gems before they attract wider attention.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2635273668","isCrawlerRequest":true}